Home /  Fact sheets /  Germany / Colorectal qualitative data
    
	
	
	
	
	
	
	
	
	
		
Check also the following factsheets: Germany, Breast, Cervical
        
	
        Country fact sheet: Germany
COLORECTAL CANCER SCREENING PROGRAMME
| Reporting year for qualitative data: | 2016 | 
| Source of qualitative data: | Other (EU Report 2017) | 
Organization of screening | |
| An individual/team/institution responsible to coordinate the programme: | Yes | 
| Dedicated budget for screening programme: | Yes | 
| Documented cancer screening policy: | Yes | 
| Nature of documentation of the policy: | Law | 
| Year programme was initiated: | 1974 | 
| Programme introduction was preceded by a pilot: | - | 
| Screening tests provided free of charge: | Yes | 
| Diagnostic tests provided free of charge: | Yes | 
| Treatment services provided free of charge: | - | 
Information system and data collection | |
| System that collects data: | Individual | 
| • Identification of eligible population: | - | 
| • Screening participation: | - | 
| • Screening test results: | - | 
| • Further assessment: | - | 
| • Final pathology diagnosis: | - | 
| • Cancer staging: | - | 
| • Treatment: | - | 
| The information system exists at national or sub-national level: | Individual: Unknown Aggregated: Unknown  | 
| The information system collects data outside the programme (opportunistic screening/private sector): | - | 
| Cancer screening data is linked with population-based cancer registry (PBCR): | No | 
Screening protocol | |
| A screening protocol or guideline: | - | 
| Year of published/updated protocol: | - | 
| Target age (min-max) and screening interval [months] for each test: | FIT (50-74 years / [ months]) gFOBT (50- years / [24 months]) Colonoscopy (55- years / [120 months])  | 
Invitations for screening and further assessment | |
| Initiatives to create population awareness by the Health Ministry/Health Authority: | - | 
| Invitations to eligible population: | |
| Source of the eligible individuals identified: | - | 
| Method of invitation: | - | 
| Screening kit included with the invitation: | - | 
| Screen positive individuals actively contacted for further assessment: | No | 
| Individuals with a precancer or cancer diagnosis actively contacted: | - | 
Quality Assurance (QA) of screening activities | |
| Documented standard operating procedure/policy for QA: | - | 
| An individual/team/institution responsible for QA: | Yes | 
| Accreditation of endoscopy units: | - | 
| Accreditation of pathology services: | - | 
| Documented performance indicators: | - | 
| Reference standards for performance indicators: | - | 
| Evaluation reports published in the last five years: | Yes | 
Performance indicators | |
| Reporting year for quantitative data: | 2016 | 
| Source of quantitative data: | Report (EU Report 2017) | 
| FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
| Target age and regional limitation if applicable: | ||||
| Invitation coverage (%): | ||||
| Participation rate (%): | ||||
| Examination coverage (%): | ||||
| Completeness of data related to screening results (%): | ||||
| Completeness of data related to information about attendance to colonoscopy assessment (%): | ||||
| Further assessment (diagnosis colonoscopy) rate (%): | ||||
| Further assessment participation rate (%): | ||||
| Detection rate of adenomas (x 1000): | ||||
| Detection rate of advanced adenomas (x 1000): | ||||
| Detection rate of colorectal cancers (x 1000): | ||||
| Positive Predictive Value of further assessment to detect adenomas (%): | ||||
| Positive Predictive Value of further assessment to detect advanced adenomas (%): | ||||
| Positive Predictive Value of further assessment to detect colorectal cancers (%): | 
Check also the following factsheets: Germany, Breast, Cervical
